Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Dolan

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
Pharmacogenomics|September 13, 2013
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patientsXueyuan Cao, Amit K Mitra, Stanley Pounds, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 19, 2011
Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancersDana Ziliak, Peter H O'Donnell, Hae Kyung Im, et al.
JAMA Oncology|June 6, 2024
Comprehensive Audiologic Analyses After Cisplatin-Based ChemotherapyVictoria A Sanchez, Paul C Dinh, Patrick O Monahan, et al.
Human Genetics|December 5, 2008
Identification of common genetic variants that account for transcript isoform variation between human populationsWei Zhang, Shiwei Duan, Wasim K Bleibel, et al.
Seminars in Oncology|March 23, 2011
An integrated genomic approach to the assessment and treatment of acute myeloid leukemiaLucy A Godley, John Cunningham, M Eileen Dolan, et al.
Plos Genetics|April 5, 2014
Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapyAmy L Stark, Ronald J Hause, Lidija K Gorsic, et al.
International Journal of Molecular Sciences|March 25, 2017
Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics ApproachMichael T Eadon, Ronald J Hause, Amy L Stark, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2011
Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemiaAmit K Mitra, Kristine R Crews, Stanley Pounds, et al.
American Journal of Human Genetics|August 5, 2014
Identification and validation of genetic variants that influence transcription factor and cell signaling protein levelsRonald J Hause, Amy L Stark, Nirav N Antao, et al.
Journal of the National Cancer Institute|March 14, 2014
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomicsLois B Travis, Sophie D Fossa, Howard D Sesso, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
Pharmacogenomics|September 13, 2013
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patientsXueyuan Cao, Amit K Mitra, Stanley Pounds, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 19, 2011
Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancersDana Ziliak, Peter H O'Donnell, Hae Kyung Im, et al.
JAMA Oncology|June 6, 2024
Comprehensive Audiologic Analyses After Cisplatin-Based ChemotherapyVictoria A Sanchez, Paul C Dinh, Patrick O Monahan, et al.
Human Genetics|December 5, 2008
Identification of common genetic variants that account for transcript isoform variation between human populationsWei Zhang, Shiwei Duan, Wasim K Bleibel, et al.
Seminars in Oncology|March 23, 2011
An integrated genomic approach to the assessment and treatment of acute myeloid leukemiaLucy A Godley, John Cunningham, M Eileen Dolan, et al.
Plos Genetics|April 5, 2014
Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapyAmy L Stark, Ronald J Hause, Lidija K Gorsic, et al.
International Journal of Molecular Sciences|March 25, 2017
Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics ApproachMichael T Eadon, Ronald J Hause, Amy L Stark, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2011
Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemiaAmit K Mitra, Kristine R Crews, Stanley Pounds, et al.
American Journal of Human Genetics|August 5, 2014
Identification and validation of genetic variants that influence transcription factor and cell signaling protein levelsRonald J Hause, Amy L Stark, Nirav N Antao, et al.
Journal of the National Cancer Institute|March 14, 2014
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomicsLois B Travis, Sophie D Fossa, Howard D Sesso, et al.
Pageof 19